CASI Pharmaceuticals Announces Poster Presentation At The 2020 AABB Virtual Annual MeetingPRNewsWire • 10/02/20
CASI Pharmaceuticals To Report Second Quarter 2020 Financial Results And Host Conference Call August 10, 2020PRNewsWire • 08/03/20
CASI Pharmaceuticals Announces Pricing Of $38,000,000 Public Offering Of Common StockPRNewsWire • 07/22/20
CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody ProgramPRNewsWire • 06/08/20